insights_auto
Nega IDXX oshdi 2,52%?
Batafsil oʻrganishchevron_right
IDXX:NASDAQ
IDEXX Laboratories Inc
542,32Â US$
arrow_upward
+2,52%(+13,31) 1K
15-okt, 11:36:53 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoIDXX tikeri uchun statistika yaratilmoqda...
Ochish
538,34Â US$
Yuqori
545,16Â US$
Past
535,28Â US$
Bozor kapitali
42,73Â mlrd
Oʻrtacha hajm
520,89Â ming
Hajmi
153,76Â ming
P/E koeffitsiyenti
38,12
52 haftalik eng yuqori
769,98Â US$
52 haftalik eng past
500,61Â US$
Aksiya boʻyicha daromad
14,23Â US$
Beta
1,55
Muomaladagi aksiyalar
78,78Â mln
Xodimlar soni
11Â ming
Ochish
538,34Â US$
Yuqori
545,16Â US$
Past
535,28Â US$
Bozor kapitali
42,73Â mlrd
Oʻrtacha hajm
520,89Â ming
Hajmi
153,76Â ming
P/E koeffitsiyenti
38,12
52 haftalik eng yuqori
769,98Â US$
52 haftalik eng past
500,61Â US$
Aksiya boʻyicha daromad
14,23Â US$
Beta
1,55
Muomaladagi aksiyalar
78,78Â mln
Xodimlar soni
11Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Yahoo Finance
·
16 soat oldin
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts
Simply Wall Street
·
1 kun oldin
IDEXX Laboratories (IDXX) Stock May Be 12% Undervalued Despite AI Acquisition
Investing.com
·
3 kun oldin
KeyBanc initiates Idexx Laboratories stock rating at Sector Weight
Profil
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.
In 2025, IDEXX estimated annual sales between $4.21 billion and $4.28 billion, with total quarterly revenue exceeding $1 billion. Wikipedia
IDEXX Laboratories Inc haqida
CEOJay Mazelsky
Xodimlar soni11Â ming
Asos solingan19-dek, 1983
Bosh ofislarWestbrook, Meyn, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytidexx.com